ストックスクリーナーアプリを入手
0.3702
2.58%
-0.0098
前日終値:
$0.38
開ける：
$0.34
24時間の取引高:
348.70K
Relative Volume:
0.65
時価総額：
$14.45M
収益：
-
当期純損益:
$-117.67M
株価収益率:
-0.1198
EPS:
-3.09
ネットキャッシュフロー:
$-101.06M
1週間 パフォーマンス:
-19.17%
1か月 パフォーマンス:
+23.40%
6か月 パフォーマンス:
-29.53%
1年 パフォーマンス:
-88.61%
1日の値動き範囲:
$0.3236
$0.3784
1週間の範囲:
$0.3236
$0.4494
52週間の値動き範囲:
$0.2195
$3.67
Athira Pharma Inc Stock (ATHA) Company Profile
名前
Athira Pharma Inc
セクター
電話
(425) 620-8501
住所
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL
ATHA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ATHA
Athira Pharma Inc
|
0.3702 | 14.84M | 0 | -117.67M | -101.06M | -3.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Athira Pharma Inc Stock (ATHA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-09-19 | ダウングレード | Mizuho | Outperform → Neutral |
| 2024-09-04 | ダウングレード | BTIG Research | Buy → Neutral |
| 2024-09-04 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-09-04 | ダウングレード | Rodman & Renshaw | Buy → Neutral |
| 2024-08-19 | 開始されました | Rodman & Renshaw | Buy |
| 2022-10-17 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
| 2022-07-07 | 開始されました | Mizuho | Buy |
| 2022-06-23 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-06-23 | ダウングレード | Jefferies | Buy → Hold |
| 2022-06-23 | ダウングレード | Stifel | Buy → Hold |
| 2022-05-10 | 開始されました | BTIG Research | Buy |
| 2022-04-21 | 開始されました | Berenberg | Buy |
| 2021-12-15 | 開始されました | Goldman | Neutral |
| 2020-10-13 | 開始されました | Goldman | Buy |
| 2020-10-13 | 開始されました | JMP Securities | Mkt Outperform |
| 2020-10-13 | 開始されました | Jefferies | Buy |
| 2020-10-13 | 開始されました | Stifel | Buy |
すべてを表示
Athira Pharma Inc (ATHA) 最新ニュース
Does Athira Pharma Inc. stock perform well during market downturnsCapitalize on fast-moving stock trends - jammulinksnews.com
Will Athira Pharma Inc. bounce back from current supportChart-Based Entry Confirmation for Beginners - Newser
What is Athira Pharma Inc. company’s growth strategyExceptional ROI - jammulinksnews.com
What are the latest earnings results for Athira Pharma Inc.Discover stocks with massive upside potential - jammulinksnews.com
What institutional investors are buying Athira Pharma Inc. stockGet expert analysis on top stock picks - jammulinksnews.com
Why is Athira Pharma Inc. stock attracting strong analyst attentionUnlock powerful market insights for success - jammulinksnews.com
Is it the right time to buy Athira Pharma Inc. stockInvest like a pro with expert recommendations - jammulinksnews.com
How volatile is Athira Pharma Inc. stock compared to the marketMaximize returns with disciplined trading - jammulinksnews.com
New Product Launches: Will They Boost Athira Pharma Inc. Stock in 2025Daily Trade Setup Forecast with Confidence - Newser
Using fundamentals and technicals on Athira Pharma Inc.Momentum Stocks with Breakout Potential - Newser
Why Athira Pharma Inc. stock attracts strong analyst attentionFree Community Shared Smart Money Signals - Newser
When is Athira Pharma Inc. stock expected to show significant growthTop Growth Tips For Fast Growth - jammulinksnews.com
What markets is PYPD expanding into Is Athira Pharma Inc. stock a good long term investment option - jammulinksnews.com
How Athira Pharma Inc. stock performs during market volatilityFree AI-Powered Trade Planning with Indicators - Newser
Can technical indicators confirm Athira Pharma Inc.’s reversalWeekly Portfolio Update with ROI Focus - Newser
Visual trend scoring systems applied to Athira Pharma Inc.Long-Term Safety Investment Analysis Report - Newser
What are analysts’ price targets for Athira Pharma Inc. in the next 12 monthsAI Powered Entry Points From AI Tools - jammulinksnews.com
What MACD signals say about Athira Pharma Inc.Free Buy Low Sell High Stock Watch - Newser
RSI Crosses Above 30 for Athira Pharma Inc. — Reversal in SightEarly Breakout Entry Point Notifications Sent - metal.it
Published on: 2025-07-29 23:41:45 - metal.it
Will Athira Pharma Inc. Stock Benefit from AI and Green Energy TrendsDaily Growth Stock Pick Reports Show Bullish Signals - metal.it
Is Now a Good Time to Reenter Athira Pharma Inc.Swing Setup With Technical Confirmation Explained - metal.it
Athira Pharma Inc. Recovery Linked to Earnings SurpriseFast Gaining Stock Screener Reports Released - metal.it
Sector ETF performance correlation with Athira Pharma Inc.Free Short Term Buy List With Stop Protection - Newser
Is Athira Pharma Inc. stock overvalued or undervaluedExpert Picks Forecasts Backed By Experts - jammulinksnews.com
How does Athira Pharma Inc. generate profit in a changing economyAchieve breakthrough performance with smart picks - jammulinksnews.com
What are Athira Pharma Inc. company’s key revenue driversCapitalize on momentum-driven investment opportunities - jammulinksnews.com
Reversal indicators forming on Athira Pharma Inc. stockShort-Term Profit Alert With Entry Forecast - Newser
Sector ETF performance correlation with Athira Pharma Inc. Smart Stock Forecast Using AI Algorithms - Newser
Athira Pharma Inc. Earnings Report Breakdown: What Investors Should KnowFree Investment Community - metal.it
What makes Athira Pharma Inc. stock price move sharplyUnlock exclusive investment alerts - jammulinksnews.com
Published on: 2025-07-27 20:04:45 - jammulinksnews.com
Buy Signal for Athira Pharma Inc. Stock Key Technical Indicators to WatchFree Stock Market Return Analysis - Newser
Is Athira Pharma Inc. a good long term investmentMarket-crushing profits - PrintWeekIndia
Athira Pharma Inc. Stock Analysis and ForecastUnprecedented profits - Autocar Professional
What drives Athira Pharma Inc. stock priceHigh-yield capital appreciation - jammulinksnews.com
Athira Pharma Inc (ATHA) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
0.15%
大文字化:
|
ボリューム (24 時間):